Skip to main content
QUCY logo

Quantum Cyber N.V. (QUCY) Stock Price & Analysis

Quantum Cyber N.V. (QUCY) — MoonshotScore 20/100 (Weak band), calculated Oct 26, 2026. Price $0.8515 (-15.69%), as of the Oct 26, 2026 trading session; market cap $19.4M.

Educational signal · not a buy or sell recommendation · How to read this

$0.8515 −$0.1585 (-15.69%) Market Cap $19.4M

Quantum Cyber N.V. · QUCY · NASDAQ

Mainz Biomed N.V. is a specialized molecular genetics company focused on developing, producing, and commercializing diagnostic solutions for life-threatening medical conditions, particularly cancer. The company actively engages in global market reach across Europe, the United States, and other international territories.

Price as of Oct 26, 2026

Key Statistics

20 of 100

MoonshotScore v2 · Quantum Cyber (QUCY)

Weak
Business Quality Poor (13)
Financial Safety Strained (31)
Valuation Bubble (8)
Growth Durability Fading (22)
Momentum Rising (76)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Bottom-tier quality, a strained balance sheet and stalling growth, and it’s expensive on top — broad distress, a capital-preservation call, not a value entry. The score also carries a risk penalty for a bankruptcy-risk score in the distress zone and losses on top of negative retained earnings. Business Quality: Poor; Financial Safety: Strained; Valuation: Bubble; Growth Durability: Fading; Momentum: Rising.

  • quarterly revenue $125,180 (Q4 FY2025, quarter ended Dec 31, 2025)
  • EPS beat 5 of 6
  • Altman Z -3.85 · Piotroski F 3

Holding back: weak fundamentals, balance-sheet strain, a rich price, soft growth

Helping: positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for QUCY (42 recorded, newest six shown)
RecordedScoreBand
20Weak
20Weak
20Weak
20Weak
20Weak
20Weak

The score was 20 in the stored Oct 24, 2026 snapshot and remains 20 in the current publication computed Oct 26, 2026 (0); the largest pillar moves were Momentum -1; the pillar moves offset under the sector-relative weighting, so the headline score is unchanged.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · Educational signal · not a buy or sell recommendation · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$0.8515
Change on the day-15.69%
52-week range$0.30 – $4.88
Market capitalisation$19.4M
Shares traded on the day591.8K

Price & events

Other perspectives

Council score for Quantum Cyber (QUCY): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

9-Factor Breakdown

Revenue Growth Weak
Gross Margin Strong
Operating Leverage Neutral
Cash Runway Neutral
R&D Intensity Strong
Insider Activity Moderate
Trading Liquidity Weak
Price Momentum Negative
News Sentiment Neutral

Legends Council

5 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Neutral read

Read on: Sep 11, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Negative
Margin of Safety Undervalued
Profit Margin Weak
Revenue Growth Negative
Debt/Equity Strong
ROE Negative
Gross Margin Strong

Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Sep 10, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.

Readings on this page are from Oct 27, 2026, except a card that shows its own read date.

Watch the QUCY film — every key number, told as a short cinematic story

~2 min · open the film

1 · What is it?

What is Quantum Cyber (QUCY), and what does it report?

Short answer · as of

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Quantum Cyber N.V. (QUCY) is listed on NASDAQ. It employs 13 people and is led by David Elliot Lazar. In Q4 FY2025 it reported revenue of $125,180 and net income of -$4M. The market values it at $19.4M.

2 · Latest results

What do the latest results show for Quantum Cyber (QUCY)?

Short answer · as of

The most recent reported quarter, Q4 FY2025, carried revenue of $125,180. Against analyst estimates the company has EPS beat 5 of 6 reports.

Quarterly income statement — 2 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q4 FY2025$125,180-$4M-$0.44 (diluted)
Q3 FY2025$125,180-$4M-$0.44 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Quantum Cyber (QUCY)?

Short answer

The MoonshotScore pillars rate positive momentum as strengths. What is holding it back is weak fundamentals, balance-sheet strain, a rich price, soft growth. The distress and quality screens read Altman Z -3.85 · Piotroski F 3. Trailing ratios: current ratio 5.56 · earnings yield -114.2% · free-cash-flow yield -59.2%.

Data-derived red flags

  • Listing risk — at $0.8515 the shares sit below the $1.00 minimum bid NASDAQ requires for continued listing.
  • Financial-distress signal — its Altman Z-Score of -3.85 sits in the distress zone (elevated bankruptcy risk).
  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
4 · What to check next?

What should you watch next at Quantum Cyber (QUCY)?

Short answer · as of

Analyst estimates on file carry FY2026 revenue $2.05M · EPS -0.49 · 1 analysts.

What the records here don't tell us

  • The next earnings date is not yet scheduled in the calendar we read.
  • The newest quarter held here (Q4 FY2025) was filed Dec 31, 2025 — 9 months ago.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does Quantum Cyber compare with its peers?

Short answer

Quantum Cyber's score ranks 11th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Advanced Biomed Inc. Common Stock (ADVB) Same industry, near in market value$2.73 Oct 26, 2026$5.24M35 5-pillar Oct 26, 2026
DarioHealth Corp. (DRIO) Same industry, near in market value$3.40 Oct 26, 2026$33.3M32 5-pillar Oct 26, 2026
ENDRA Life Sciences Inc. (NDRA) Same industry, near in market value$4.82 Oct 26, 2026$7.23M31 5-pillar Oct 26, 2026
Precipio, Inc. (PRPO) Same industry, near in market value$19.35 Oct 26, 2026$35.8M26 5-pillar Oct 26, 2026
MDxHealth SA (MDXH) Same industry, near in market value$0.19 Oct 26, 2026$17.5M24 5-pillar Oct 26, 2026
Burning Rock Biotech Limited (BNR) Same industry, near in market value$11.15 Oct 26, 2026$12.4M24 5-pillar Oct 26, 2026
Star Equity Holdings, Inc. (STRR) Same industry, near in market value$9.89 Oct 26, 2026$36.5M24 5-pillar Oct 26, 2026
Bionano Genomics, Inc. (BNGO) Same industry, near in market value$1.16 Oct 26, 2026$13.3M21 5-pillar Oct 26, 2026
Neuronetics, Inc. (STIM) Same industry, near in market value$2.24 Oct 26, 2026$171M21 5-pillar Oct 26, 2026
Biodesix, Inc. (BDSX) Same industry, near in market value$21.26 Oct 26, 2026$172M21 5-pillar Oct 26, 2026
Quantum Cyber (QUCY) — this page$0.8515$19.4M20
Intelligent Bio Solutions Inc. (INBS) Same industry, near in market value$1.64 Oct 26, 2026$5.47M19 5-pillar Oct 26, 2026
Trinity Biotech plc (TRIB) Same industry, near in market value$7.11 Oct 26, 2026$144M19 5-pillar Oct 26, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Analyst targets & estimates

What analysts have on file

Revenue estimate
$2.05M
EPS estimate
$-0.49

Measured against a quoted price of $0.8515 (as of Oct 26, 2026).

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Aug 11, 2026

Transactions
20
Identified insiders
6
Purchases
0
Sales
0
Other transactions
20

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

What has been published about Quantum Cyber (QUCY)?

Read these with our analysis →

Investor Questions: QUCY Stock

These answers are editorial: 1 of these 9 answers is drawn from the QUCY research dossier (written Jun 15, 2026 by gemini-2.5-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for QUCY?

QUCY carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is QUCY a good stock to buy?

Stock Expert AI does not rate QUCY buy, sell or hold. Quantum Cyber N.V. carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the QUCY stock price today?

The last price recorded on this page for Quantum Cyber N.V. (QUCY) is $0.8515, as of the Oct 26, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

How does Mainz Biomed N.V. navigate regulatory approval processes for its diagnostic solutions?

While specific details of Mainz Biomed N.V.'s regulatory track record are not provided, as a company operating in the medical diagnostics sector, it must adhere to stringent regulatory requirements in each market it targets.

What are the key factors to evaluate for QUCY?

Quantum Cyber N.V. (QUCY) holds a MoonshotScore in the low range. Analysts target $9.00 (+957%). The company does not currently offer a dividend yield, consistent with its growth-oriented strategy and current negative profitability profile. Not financial advice.

How frequently does QUCY data refresh on this page?

QUCY's price is the last quote we recorded, from the Oct 26, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven QUCY's recent stock price performance?

Quantum Cyber N.V. (QUCY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized focus on molecular genetic cancer diagnostics, addressing a high-demand medical area. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider QUCY overvalued or undervalued right now?

Quantum Cyber N.V. (QUCY) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Analysts target $9.00 (+957%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of QUCY?

Fractional-share availability for Quantum Cyber N.V. (QUCY) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources — records for every figure on this page (20 figures)

The 20 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.

"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.

FMP — 9 facts from Financial Modeling Prep endpoint families

FMP facts used on this page
Fact IDFactValue as shownAs ofTierSource
px.lastLatest provided price$0.8515FMPFinancial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-26T21:54:36.130Z.
px.changeChange on the day-15.69%FMPFinancial Modeling Prep (FMP) · quote
px.mcapMarket capitalisation$19.4MFMPFinancial Modeling Prep (FMP) · quote — Date unknown Market cap record date: 2026-10-26. FMP quote timestamp: 2026-10-26T20:00:00.000Z. Captured from FMP at 2026-10-26T21:54:35.014Z. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares.
px.change_absChange on the day, in dollars−$0.1585FMPFinancial Modeling Prep (FMP) · quote
fin.q_revenueRevenue, Q4 FY2025$125,180FMPFinancial Modeling Prep (FMP) · income statement (quarterly)
px.volumeShares traded on the day591.8KFMPFinancial Modeling Prep (FMP) · quote
fin.q_incomeNet income, Q4 FY2025-$4MFMPFinancial Modeling Prep (FMP) · income statement (quarterly)
fin.q_tableQuarterly income statement2 quarters through Q4 FY2025FMPFinancial Modeling Prep (FMP) · income statement (quarterly), as filed
own.insidersInsider transactions via FMP20 transactions · 0 purchases, 0 sales, 20 other transactions · 6 identified insiders · of the newest 100 records, those within the last 180 days, newest dated Aug 11, 2026FMPFinancial Modeling Prep (FMP), carrying Form 4 transaction records — Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

UNRECORDED — 9 facts from stored observations whose source was not recorded

UNRECORDED facts used on this page
Fact IDFactValue as shownAs ofTierSource
earn.historyReported versus estimated, recent quartersEPS beat 5 of 6UNRECORDEDStored earnings-history observation — Captured 2026-10-24 · Expired observation
fin.scoresDistress and quality screensAltman Z -3.85 · Piotroski F 3UNRECORDEDStored financial-scores observation — Captured 2026-10-26
px.range5252-week range$0.30 – $4.88UNRECORDEDStored company-profile observation — Captured 2026-10-24
id.employeesEmployees13UNRECORDEDStored company-profile observation — Captured 2026-10-24
id.ceoChief executiveDavid Elliot LazarUNRECORDEDStored company-profile observation — Captured 2026-10-24
fin.ratiosReturn and yield ratios (trailing twelve months)current ratio 5.56 · earnings yield -114.2% · free-cash-flow yield -59.2%—UNRECORDEDStored key metrics — Date unknown
earn.estimatesAnalyst estimates, next fiscal yearFY2026 revenue $2.05M · EPS -0.49 · 1 analystsUNRECORDEDStored analyst estimates — Captured 2026-08-21 · Expired observation
earn.est_revenueRevenue estimate, FY2026$2.05MUNRECORDEDStored analyst estimates — Captured 2026-08-21 · Expired observation
earn.est_epsEPS estimate, FY2026$-0.49UNRECORDEDStored analyst estimates — Captured 2026-08-21 · Expired observation

OURS — 2 facts from Stock Expert AI's own score and rank

OURS facts used on this page
Fact IDFactValue as shownAs ofTierSource
ours.moonshotMoonshotScore v220 of 100 · Weak · pillars 13 / 31 / 8 / 22 / 76OURSStock Expert AI MoonshotScore v2 engine
ours.moonshot_changeMoonshotScore movement20 (stored snapshot Oct 24, 2026) → 20 (current publication computed Oct 26, 2026) (0)OURSStock Expert AI current score publication and immutable score snapshots
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.